Early and long-term usage of liraglutide benefits the comprehensive management of type 2 diabetes
10.3760/cma.j.issn.1000-6699.2013.05.027
- VernacularTitle:利拉鲁肽早期和长期应用为2型糖尿病综合管理带来益处
- Author:
Juming LU
- Publication Type:Journal Article
- Keywords:
Liraglutide;
Diabetes mellitus,type 2;
β-cell;
Comprehensive management
- From:
Chinese Journal of Endocrinology and Metabolism
2013;(5):后插11-后插15
- CountryChina
- Language:Chinese
-
Abstract:
[Summary] Treatment of type 2 diabetes which is characterized by the progressive β-cell dysfunction currently faces various challenges.A new generation of drug need to protect β-cell function in early stage of the disease.Liraglutide is a glucagon-like peptide 1 analogue and provides a new therapeutic option due to its unique clinical efficacy.Early and long-term usage of liraglutide improves glycemic control,reduces body weight and systolic blood pressure,as well as protects β-cell function for the patients with diabetes.
